The landscape of neurodevelopmental health has undergone a profound transformation over the last decade. As the number of children and adolescents diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) continues to climb globally, a landmark study has uncovered a critical shift in who is actually receiving these diagnoses. New research indicates that the clinical profile of the "typical" patient is changing, with those diagnosed today more closely resembling the general population than those identified ten years ago.
The study, a collaborative effort led by the Barcelona Institute for Global Health (ISGlobal)—a center supported by the "la Caixa" Foundation—and Aarhus University in Denmark, provides a nuanced look at the evolving nature of neurodevelopmental identification. Published in the prestigious journal JAMA Psychiatry, the findings suggest that the recent surge in ADHD and ASD cases may not be driven solely by a biological increase in these conditions, but rather by significant changes in the societal and clinical mechanisms used to identify them.
By analyzing extensive data from the Danish national registries, researchers found that the gap between the diagnosed population and the general public is narrowing. This convergence suggests that individuals who might have been overlooked or categorized as "neurotypical" in previous decades are now being brought into the diagnostic fold, fundamentally altering the demographic and socioeconomic makeup of the patient population.
Tracking changes in ADHD and autism diagnoses
To understand the magnitude of this shift, the research team looked back at decades of established medical literature. Historically, ADHD and ASD diagnoses have been strongly associated with a specific set of risk factors and demographic markers. Previous studies have consistently identified that children diagnosed with these conditions were more likely to have been born prematurely or at a low birth weight. Furthermore, they were frequently found to come from families facing socioeconomic challenges, such as lower levels of parental education or lower household income.
Other established markers included a family history of psychiatric disorders and a pattern of high healthcare utilization in the years leading up to a formal diagnosis. These characteristics created a distinct profile for the "average" child with ADHD or autism—a profile that often skewed toward those with more pronounced clinical needs or those facing significant environmental stressors.
However, as the prevalence of these diagnoses has soared, researchers began to wonder if these traditional associations still held true. To investigate, the team undertook a massive longitudinal analysis, examining records from more than 2.1 million children and adolescents born in Denmark. The study period, spanning from 2012 to 2022, allowed the researchers to compare the characteristics of over 71,000 young people diagnosed with ADHD or ASD against a control group of more than 713,000 individuals who had not received either diagnosis.
The scale of the Danish data provided a unique opportunity to track subtle shifts in the population over time. Because Denmark maintains comprehensive, centralized health and social registries, the researchers were able to follow the trajectories of millions of individuals with a level of precision that is rarely possible in other countries. This allowed them to see not just how many children were being diagnosed, but who those children were in terms of their biological start in life and their family’s social standing.
Differences narrowed over 10 years
The core of the study’s findings lies in the "narrowing gap." While young people diagnosed with ADHD or ASD are still statistically more likely than their peers to exhibit the risk factors mentioned—such as premature birth or socioeconomic disadvantage—the intensity of these associations has seen a steady and significant decline.
